Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PsyRx CNS Bio-TechXTAE:PSRX +3.09%10 OCF Yield % is 0.00 as of Aug. 06, 2026. GuruFocus rates XTAE:PSRX with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 1,006 Drug Manufacturers companies, PsyRx CNS Bio-Tech ranks worse than 99403.48% on this metric.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
The historical rank and industry rank for PsyRx CNS Bio-Tech's OCF Yield % or its related term are showing as below:
XTAE:PSRX's OCF Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.645 * Ranked among companies with meaningful OCF Yield % only.
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
PsyRx CNS Bio-Tech OCF Yield % Related Terms
PsyRx CNS Bio-Tech OCF Yield % Historical Data
* Premium members only.
The historical data trend for PsyRx CNS Bio-Tech's OCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PsyRx CNS Bio-Tech OCF Yield % Chart
PsyRx CNS Bio-Tech Annual Data
Trend
OCF Yield %
PsyRx CNS Bio-Tech Semi-Annual Data
OCF Yield %
XTAE:PSRX vs ZTS, UTHR, VTRS: OCF Yield % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PsyRx CNS Bio-Tech's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PsyRx CNS Bio-Tech OCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PsyRx CNS Bio-Tech's OCF Yield % distribution charts can be found below:
* The bar in red indicates where PsyRx CNS Bio-Tech's OCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PsyRx CNS Bio-Tech (XTAE:PSRX) has a OCF Yield % of 0.00 as of Aug. 06, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PsyRx CNS Bio-Tech and its competitors. According to the industry distribution chart, PsyRx CNS Bio-Tech ranks #999999 out of 1006 companies in the Drug Manufacturers industry.
Is PsyRx CNS Bio-Tech's OCF Yield % too high?
PsyRx CNS Bio-Tech's current OCF Yield % is 0.00. Based on the distribution chart, PsyRx CNS Bio-Tech ranks #999999 out of 1006 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, PsyRx CNS Bio-Tech has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does PsyRx CNS Bio-Tech's OCF Yield % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, PsyRx CNS Bio-Tech ranks #999999 out of 1006 companies for OCF Yield %. This places PsyRx CNS Bio-Tech in the lower half of its industry. The industry median OCF Yield % is 3.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.65, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on PsyRx CNS Bio-Tech and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PsyRx CNS Bio-Tech's current OCF Yield % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PsyRx CNS Bio-Tech stock overvalued right now?
PsyRx CNS Bio-Tech (XTAE:PSRX) has a current OCF Yield % of 0.00. The current OCF Yield % is 0.00. PsyRx CNS Bio-Tech's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For PsyRx CNS Bio-Tech (XTAE:PSRX), the current OCF Yield % is 0.00 as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PsyRx CNS Bio-Tech Ltd Formerly Cannabotech Ltd is engaged in the research and development of cannabis-based drugs. It is a biomedical company focused on the benefits of cannabinoids and medicinal mushrooms, applying the pure power of nature and science to health issues.
10GF Score
Get the complete analysis for XTAE:PSRX
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTAE:PSRX has been successfully added to your 
